Literature DB >> 958512

The effects of methacholine and calcium deprivation on the release of the false transmitter, alpha-methyladrenaline, from the isolated rabbit heart.

H Fuder, E Muscholl, R Wegwart.   

Abstract

1. Anaesthetized rabbits were infused for 20 min with 85 mug-kg-1-min-1(+/-)-alpha-methyladrenaline. The hearts dissected 15 min after the infusion contained 1.49 mug/g alpha-methyladrenaline; the endogenous noradrenaline content was correspondingly decreased. 2. Hearts from alpha-methyladrenaline-infused animals were isolated with the right sympathetic nerves intact and perfused. Ventricular rate, right atrial and right ventricular tensions were recorded using the transverse method. 3. Electrical stimulation (10 Hz, 1 ms, 1 min) of sympathetic nerves, perfusion with the nicotinic drug, p-aminophenethyltrimethylammonium (PAPETA) or perfusion with 54 mM KCl (high K+) solution evoked an output of both alpha-methyladrenaline and noradrenaline. The ratio of the amines in the perfusates was similar to that found in the hearts after termination of the experiments or in non-perfused hearts. 4. Methacholine perfused before and during sympathetic nerve stimulation, PAPETA or high K+ inhibited the release of both false transmitter and noradrenaline. These effects were reversed by atropine. Similarly, lowering the calcium chloride concentration of the medium from 1.8 to 0.1 mM decreased amine outputs. This was reversed by washing. 5. Tyramine evoked a preferential release of the false transmitter that was not altered by methacholine or calcium deprivation. 6. These experiments whow that the muscarinic inhibition of neuronal noradrenaline release and the requirement of calcium ions for its liberation by depolarizing stimuli can be extended to a false transmitter amine. It is suggested that the proportion of alpha-methyladrenaline to noradrenaline occurring in the perfusate during administration of tyramine reflects the relative concentrations of the amines in the axoplasm.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 958512     DOI: 10.1007/BF00507345

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  14 in total

1.  [Noradrenalin loss from the isolated rabbit heart following sympathetic nerve irritation and its pharmacological alteration].

Authors:  S HUKOVIC; E MUSCHOLL
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1962

2.  Release of dopamine beta-hydroxylase and chromogranin A upon stimulation of the splenic nerve.

Authors:  A D Smith; W P De Potter; E J Moerman; A F De Schaepdryver
Journal:  Tissue Cell       Date:  1970       Impact factor: 2.466

3.  Specificity of some ganglion stimulants.

Authors:  R B Barlow; F Franks
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

4.  Tyramine does not release noradrenaline from splenic nerve by exocytosis.

Authors:  I W Chubb; W P De Potter; A F De Schaepdryver
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1972       Impact factor: 3.000

5.  A muscarinic inhibition of the noradrenaline release evoked by postganglionic sympathetic nerve stimulation.

Authors:  K Löffelholz; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

6.  The effects of inorganic ions on the storage and uptake of H3-norepinephrine by rat heart slices.

Authors:  D F Bogdanski; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1969-02       Impact factor: 4.030

7.  Muscarinic inhibition of potassium-induced noradrenaline release and its dependence on the calcium concentration.

Authors:  M P Dubey; E Muscholl; A Pfeiffer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

8.  On the mechanism of release of norepinephrine from cat spleen slices by sodium deprivation and calcium pretreatment.

Authors:  A G Garcia; S M Kirpekar
Journal:  J Pharmacol Exp Ther       Date:  1975-02       Impact factor: 4.030

9.  Release of noradrenaline from the cat spleen by sodium deprivation.

Authors:  A G Garcia; S M Kirpekar
Journal:  Br J Pharmacol       Date:  1973-04       Impact factor: 8.739

10.  [Functional importance of liberation of dihydroxyephedrine and dihydroxypseudoephedrine as "false" sympathetic transmitter substances in the heart].

Authors:  R Lindmar; E Muscholl; E Sprenger
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967
View more
  3 in total

1.  Presence of muscarinic inhibitory and absence of nicotinic excitatory receptors at the terminal sympathetic nerves of chicken hearts.

Authors:  U Engel; K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-12       Impact factor: 3.000

2.  The use of the De Deckere-Ten Hoor preparation for study of nicotinic and potassium-evoked dopamine beta-hydroxylase release from the rabbit heart.

Authors:  B Jilg; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

3.  Sympathetic Nerve Stimulation on the perfused rat heart. Affinities of N-methylatropine and pirenzepine at pre- and postsynaptic muscarine receptors.

Authors:  H Fuder; D Rink; E Muscholl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-02       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.